InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.

Tellus BioVentures is a U.S.-based biotechnology investment fund focused on early-stage innovation and company formation in life sciences. The firm invests in private biotech ventures at the Seed stage and participates in Series A investments.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Tellus BioVentures is a biotechnology investment fund that focuses on early-stage innovation and company formation. Founded in 2019, the organization aims to uncover and accelerate promising life science innovations, enabling talented entrepreneurs and innovators to develop therapeutics for patients with unmet medical needs. Tellus invests in private biotech ventures at the Seed stage, often as the lead or sole investor, and participates in Series A investments. The firm also launches and funds de novo companies to advance significant innovations that may lack the necessary resources for efficient progress, providing management support and development expertise to help portfolio companies achieve critical milestones.
Tellus BioVentures invests primarily in private biotech ventures at the Seed stage, often as the lead or sole investor, and also participates in Series A investments. The organization is committed to launching and funding de novo companies that advance significant innovations lacking necessary resources for efficient progress.
Tellus BioVentures provides management support and development expertise to its portfolio companies, helping them achieve critical milestones. The firm identifies value-inflection points and operates hands-on to transform innovative science into viable therapies for patients.
Tellus BioVentures focuses on early-stage biotech ventures, primarily at the Seed stage, and participates in Series A investments. They look for companies that are developing therapeutics for unmet medical needs, particularly in the biotech and healthcare sectors.
Founders interested in pitching to Tellus BioVentures should prepare a detailed presentation that outlines their business model, market opportunity, and the specific therapeutic innovations they are pursuing. While specific application forms are not mentioned, reaching out through their website is recommended.
Tellus BioVentures distinguishes itself by often acting as the lead or sole investor in its ventures, providing not only capital but also management support and development expertise. This dual approach helps portfolio companies achieve critical milestones more effectively.
Tellus BioVentures primarily invests in private biotech ventures based in the United States, focusing on companies that are addressing significant medical needs.
While specific check sizes are not disclosed, Tellus BioVentures typically invests at the Seed stage and participates in Series A rounds, often taking a leading role in funding.
Tellus BioVentures provides ongoing management support and development expertise to its portfolio companies, helping them navigate challenges and achieve their goals.
Superscout Pro
Is this page right?Reviewed · How the research works